UBUX:F:F-UBS (Irl) ETF Public Limited Company - Factor MSCI USA Quality UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 41.63

Change

-0.12 (-0.28)%

Market Cap

USD 0.07B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-30 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

+0.08 (+0.30%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

-0.05 (-0.09%)

USD 115.53B
SXR8:F iShares Core S&P 500 UCITS ETF..

N/A

USD 96.59B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

N/A

USD 94.63B
SXRZ:F iShares VII PLC - iShares Nikk..

N/A

USD 57.94B
XDNY:F Xtrackers MSCI Japan ESG Scree..

N/A

USD 54.05B
VUAA:F Vanguard S&P 500 UCITS Acc

-0.07 (-0.07%)

USD 51.63B
VUSA:F Vanguard Funds Public Limited ..

+0.18 (+0.19%)

USD 51.63B
XJSE:F Xtrackers II - Japan Governmen..

+0.08 (+1.07%)

USD 40.74B
0ZC:F Zscaler Inc

-3.10 (-2.00%)

USD 37.92B

ETFs Containing UBUX:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 19.08% 85% B 73% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 19.08% 82% B 65% D
Trailing 12 Months  
Capital Gain 34.27% 90% A- 80% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 34.27% 88% B+ 71% C-
Trailing 5 Years  
Capital Gain 100.58% 96% N/A 85% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 100.58% 96% N/A 73% C
Average Annual (5 Year Horizon)  
Capital Gain 14.19% N/A N/A 77% C+
Dividend Return 14.19% N/A N/A 70% C-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 19.97% N/A N/A 64% D
Risk Adjusted Return 71.04% N/A N/A 84% B
Market Capitalization 0.07B 21% F 27% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.